Last updated: January 25, 2024
Sponsor: Zimmer Biomet
Overall Status: Terminated
Phase
N/A
Condition
Chest Trauma
Treatment
RibFix Advantage
Clinical Study ID
NCT05179005
0719-02
Ages 18-80 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- 18-80 years of age, male or female
- Underwent reconstruction of the chest wall between February 2019 and September 2021with RibFix Advantage™ for the fixation, stabilization, or fusion of rib fractures
- Minimum amount of follow-up data available, including one visit post-surgery
- Willing and able to sign an Informed Consent for research
- Willing and able to and complete a post-operative follow-up survey at least 3 monthspost-surgery
Exclusion
Exclusion Criteria:
- Latent or active infection with positive culture at the time of implantation
- Documented history of metal sensitivity
- Documented psychiatric condition preventing the patient from following post-op careinstructions
- Fixation of the first and/or second (true) vertebrosternal rib
- Bilateral rib fractures
- Concurrent surgical procedures (i.e. splenectomy, aortic disruption repair, diaphragminjury repair, etc.) performed during the same hospitalization
- Lung injury (open pneumothorax, tension pneumothorax, hemothorax > 1L, pulmonarycontusion requiring mechanical ventilation)
Study Design
Total Participants: 1
Treatment Group(s): 1
Primary Treatment: RibFix Advantage
Phase:
Study Start date:
April 20, 2023
Estimated Completion Date:
December 31, 2023
Study Description
Connect with a study center
UCI Health Surgery Services
Orange, California 92868
United StatesSite Not Available
University Hospitals Cleveland Medical Center
Cleveland, Ohio 44106
United StatesSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.